Latest action: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Referred to one or more standing committees for review, hearings, and possible markup.
Specific committees not parsed from action data.
The committee may hold hearings, amend the bill, or let it die without action.
Next: Reported
Full chamber floor — Speaker / Majority Leader controls scheduling
Bill restricts certain research involving children to protect them from harm.
The problem
Concerns exist that some research studies involving children may pose health or safety risks without sufficient protections or oversight of participant safety.
The proposal
The bill would establish new requirements and limitations on research studies that include children as participants, likely increasing review standards.
The impact
Researchers, children, medical institutions, and families would be affected through new rules governing child participation in studies and research projects.
Stricter requirements could better protect children participating in research from potential harm or adverse effects. Review processes might catch risky studies before they involve young participants. Families would have clearer information about what research entails.
New standards could require clearer explanations to parents and children about research risks and benefits. Families would make more informed decisions about participation. Documentation of consent could become more thorough and transparent.
Additional review requirements could increase accountability for researchers and institutions. Regular monitoring and reporting might prevent problematic studies from continuing. Independent review boards could have enhanced authority to protect participants.
Stronger protections could increase trust in medical research among families and communities. Public confidence in research institutions may improve with visible safety measures. Long-term participation in future studies could increase.
Additional review requirements could slow down important medical studies involving children. Compliance costs for institutions might increase significantly. Resources spent on extra paperwork could reduce funding available for actual research.
Restrictions could make it harder to conduct necessary studies on child health conditions and treatments. Some beneficial research might not be approved due to new limitations. Development of pediatric medicines could be slowed.
Without seeing the actual bill text, requirements are unclear and could be interpreted differently by different institutions. Inconsistent application might occur across states and research centers. Some rules could be overly broad or too restrictive.
Expanded consent processes could be lengthy and complicated for parents to navigate. Some families seeking helpful experimental treatments might face new barriers. Administrative requirements could discourage participation in legitimate studies.
Generated by AI from the bill text. Not a prediction and not legal or policy advice. The percentage is the model's own rating of each item — self-reported, and not a measure of how accurate it is.
Loading map…
Loading...
0 citizens have already voted
Free · No spam · See how your representatives voted
Be the first to weigh in
Your vote starts the conversation
How citizen engagement works
Citizens vote & comment
Public opinion data is aggregated and updated in real time.
Patterns become visible
Representatives can see constituent sentiment broken down by district.
Your voice on the record
Contact your rep directly — one constituent call can shift a staffer's priority list.
Research shows that constituent contacts — especially calls — are among the most effective ways to influence a legislator's position on active bills.
Other bills in this policy area
SRES 929
A resolution expressing the sense of the Senate regarding equity stakes held by the Federal Government in private companies.
HR 5235
Skills-Based Federal Contracting Act of 2025
HR 2332
SHARE Act of 2026
HR 9191
National Fossil Act of 2026
Individual contributions, grouped by employer · FEC
Where their individual donors work · 2026 cycle
Money from people who work there, not from the company. Not tied to this bill.
Itemized individual contributions via FEC, grouped by the employer each contributor self-reported. Companies and unions cannot contribute to federal candidates from their treasuries, so these totals are money from people who work at an employer — never from the organization itself. They are campaign contributions covering a full election cycle and are not connected to this bill.
Senate LDA lobbying disclosures
Couldn't load lobbying disclosures right now.